Rituximab ADCC Assay Target Cells (WIL2-S) from Krishgen Biosystems

Supplier Page

Supplier Page from
Krishgen Biosystems for
Rituximab ADCC Assay Target Cells (WIL2-S)

Get Pricing

Description

The therapeutic antibody (biosimilar) binds to specific antigens of Target Cells (WIL2-S) which inturn bind Effector cells to initiate ADCC killing pathway